{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T07:08:47Z","timestamp":1788764927970,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002807","name":"Kankeronderzoekfonds Limburg","doi-asserted-by":"publisher","award":["PRECEDE-2"],"award-info":[{"award-number":["PRECEDE-2"]}],"id":[{"id":"10.13039\/501100002807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.prp.2026.156631","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T16:05:15Z","timestamp":1786637115000},"page":"156631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["An independent evaluation of an architectural-based scoring system for renal cell carcinoma risk-stratification"],"prefix":"10.1016","volume":"287","author":[{"given":"Jaycey F.","family":"Kelly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaleesa R.M.","family":"van der Meer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Lommen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregorio E.","family":"Fazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen R.G.J.","family":"Weinans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella M.I.I.","family":"Baldewijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram","family":"Ramaekers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Marcelissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joep G.","family":"van Roermund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kerkhofs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen J.B.","family":"Aarts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"de Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo J.","family":"Schouten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iryna V.","family":"Samarska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim M.","family":"Smits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.prp.2026.156631_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.prp.2026.156631_bib2","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1186\/s12885-025-14900-8","article-title":"Renal cell carcinoma detection: a systematic review in diagnostic urinary biomarkers","volume":"25","author":"Kelly","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2026.156631_bib3","article-title":"Renal cell carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"1","key":"10.1016\/j.prp.2026.156631_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14010239","article-title":"Prognostic Factors for Localized Clear Cell Renal Cell Carcinoma and Their Application in Adjuvant Therapy","volume":"14","author":"Mattila","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"10451","key":"10.1016\/j.prp.2026.156631_bib5","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(24)00917-6","article-title":"Renal cell carcinoma","volume":"404","author":"Young","year":"2024","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.prp.2026.156631_bib6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.euo.2019.07.011","article-title":"Diagnostic DNA Methylation Biomarkers for Renal Cell Carcinoma: A Systematic Review","volume":"4","author":"Lommen","year":"2021","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.prp.2026.156631_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2023.152223","article-title":"Morphological characteristics of SETD2-mutated locally advanced clear cell renal cell carcinoma: Comparison with BAP1-mutated clear cell renal cell carcinoma","volume":"68","author":"Takeda","year":"2024","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1016\/j.prp.2026.156631_bib8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.humpath.2022.10.009","article-title":"Deciphering intratumor heterogeneity in clear cell renal cell carcinoma utilizing clinicopathologic and molecular platforms","volume":"130","author":"Vormittag-Nocito","year":"2022","journal-title":"Hum. Pathol."},{"issue":"6","key":"10.1016\/j.prp.2026.156631_bib9","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.21037\/tau-20-799","article-title":"Validation of the world health organization\/international society of urological pathology grading for Chinese patients with clear cell renal cell carcinoma","volume":"9","author":"Xiao","year":"2020","journal-title":"Transl. Androl. Urol."},{"issue":"6","key":"10.1016\/j.prp.2026.156631_bib10","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/his.13311","article-title":"Clear cell renal cell carcinoma: validation of World Health Organization\/International Society of Urological Pathology grading","volume":"71","author":"Dagher","year":"2017","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.prp.2026.156631_bib11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/PAS.0000000000001025","article-title":"Architectural Patterns are a Relevant Morphologic Grading System for Clear Cell Renal Cell Carcinoma Prognosis Assessment: Comparisons With WHO\/ISUP Grade and Integrated Staging Systems","volume":"42","author":"Verine","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"issue":"17","key":"10.1016\/j.prp.2026.156631_bib12","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1200\/JCO.2001.19.17.3792","article-title":"Validation of the ucla integrated staging system for patients with renal cell carcinoma","volume":"19","author":"Zisman","year":"2001","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2026.156631_bib13","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/S0022-5347(05)64153-5","article-title":"An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score","volume":"168","author":"Frank","year":"2002","journal-title":"J. Urol."},{"issue":"7","key":"10.1016\/j.prp.2026.156631_bib14","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/cncr.11234","article-title":"Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials","volume":"97","author":"Leibovich","year":"2003","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.prp.2026.156631_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/2056-4538.70030","article-title":"Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markers: an update after ISUP\/WHO 2022 classification","volume":"11","author":"Odeh","year":"2025","journal-title":"J. Pathol. Clin. Res."},{"issue":"3","key":"10.1016\/j.prp.2026.156631_bib16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0895-4356(90)90009-E","article-title":"A large-scale prospective cohort study on diet and cancer in The Netherlands","volume":"43","author":"van den Brandt","year":"1990","journal-title":"J. Clin. Epidemiol."},{"issue":"1","key":"10.1016\/j.prp.2026.156631_bib17","first-page":"19","article-title":"Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive","volume":"29","author":"Casparie","year":"2007","journal-title":"Cell. Oncol."},{"issue":"5","key":"10.1016\/j.prp.2026.156631_bib18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3892\/ol.2023.13760","article-title":"Histologic re\u2011evaluation of a population\u2011based series of renal cell carcinomas from The Netherlands Cohort Study according to the 2022 ISUP\/WHO classification","volume":"25","author":"Odeh","year":"2023","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.prp.2026.156631_bib19","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.eururo.2017.12.018","article-title":"Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers","volume":"73","author":"Paner","year":"2018","journal-title":"Eur. Urol."},{"key":"10.1016\/j.prp.2026.156631_bib20","series-title":"Urinary and male genital tumours and WHO Classification of Tumours","author":"Organization","year":"2022"},{"issue":"3","key":"10.1016\/j.prp.2026.156631_bib21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/PAS.0b013e318270f71c","article-title":"A novel grading system for clear cell renal cell carcinoma incorporating tumor necrosis","volume":"37","author":"Delahunt","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"issue":"4","key":"10.1016\/j.prp.2026.156631_bib22","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.eururo.2016.05.034","article-title":"Application of the Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear Cell Renal Cell Carcinoma in Contemporary Patients","volume":"71","author":"Parker","year":"2017","journal-title":"Eur. Urol."},{"issue":"3","key":"10.1016\/j.prp.2026.156631_bib23","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/ije\/31.3.699","article-title":"Regression Modelling Strategies with Applications to Linear Models, Logistic Regression, and Survival Analysis. Frank E Harrell Jr, New York: Springer 2001, pp. 568, $79.95. ISBN 0-387-95232-2","volume":"31","author":"May","year":"2002","journal-title":"Int. J. Epidemiol."},{"issue":"4","key":"10.1016\/j.prp.2026.156631_bib24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4103\/tjem.tjem_182_23","article-title":"Receiver operating characteristic curve analysis in diagnostic accuracy studies: A guide to interpreting the area under the curve value","volume":"23","author":"\u00c7orbac\u0131o\u011flu","year":"2023","journal-title":"Turk. J. Emerg. Med."},{"issue":"1","key":"10.1016\/j.prp.2026.156631_bib25","article-title":"Sample size, power and effect size revisited: simplified and practical approaches in pre-clinical, clinical and laboratory studies","volume":"31","author":"Serdar","year":"2021","journal-title":"Biochem. Med. (Zagreb. )"},{"key":"10.1016\/j.prp.2026.156631_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2019.10.052","article-title":"Ontological analyses reveal clinically-significant clear cell renal cell carcinoma subtypes with convergent evolutionary trajectories into an aggressive type","volume":"51","author":"Cai","year":"2020","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.prp.2026.156631_bib27","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.cell.2018.03.043","article-title":"Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal","volume":"173","author":"Turajlic","year":"2018","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.prp.2026.156631_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2024.100590","article-title":"Prognostic Impact and Genomic Backgrounds of Renal Parenchymal Infiltration or Micronodular Spread in Nonmetastatic Clear Cell Renal Cell Carcinoma","volume":"37","author":"Tanaka","year":"2024","journal-title":"Mod. Pathol."},{"issue":"8","key":"10.1016\/j.prp.2026.156631_bib29","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/PAS.0b013e3181e4ee32","article-title":"A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors","volume":"34","author":"Sica","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"issue":"1","key":"10.1016\/j.prp.2026.156631_bib30","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13148-021-01084-8","article-title":"Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markers","volume":"13","author":"Joosten","year":"2021","journal-title":"Clin. Epigenetics"},{"issue":"9","key":"10.1016\/j.prp.2026.156631_bib31","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.56434\/j.arch.esp.urol.20247709.148","article-title":"Computed Tomography Measures of Perinephric Adipose Tissue and C-Reactive Protein-to-Albumin Ratio are Associated with Common Prognostic Models for Nonmetastatic Clear Cell Renal Cell Carcinoma Patients","volume":"77","author":"Liu","year":"2024","journal-title":"Arch. Esp. Urol."},{"key":"10.1016\/j.prp.2026.156631_bib32","article-title":"The significance of sarcomatoid and rhabdoid dedifferentiation in renal cell carcinoma","volume":"33","author":"Hahn","year":"2022","journal-title":"Cancer Treat. Res. Commun."},{"issue":"1","key":"10.1016\/j.prp.2026.156631_bib33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40644-025-00875-z","article-title":"Preoperative prediction of WHO\/ISUP grade of ccRCC using intratumoral and peritumoral habitat imaging: multicenter study","volume":"25","author":"Chen","year":"2025","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.prp.2026.156631_bib34","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3389\/fimmu.2018.00563","article-title":"Immunological Approaches Towards Cancer and Inflammation: A Cross Talk","volume":"9","author":"Qu","year":"2018","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.prp.2026.156631_bib35","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1089\/jir.2022.0172","article-title":"Analysis of Immune and Inflammatory Microenvironment Characteristics of Noncancer End-Stage Liver Disease","volume":"43","author":"Wang","year":"2023","journal-title":"J. Interferon Cytokine Res."},{"issue":"1","key":"10.1016\/j.prp.2026.156631_bib36","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.21037\/atm.2019.01.50","article-title":"Revisiting AJCC TNM staging for renal cell carcinoma: quest for improvement","volume":"7","author":"Swami","year":"2019","journal-title":"Ann. Transl. Med."},{"issue":"1","key":"10.1016\/j.prp.2026.156631_bib37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/ckj\/sfaa188","article-title":"External validation of prognostic models: what, why, how, when and where?","volume":"14","author":"Ramspek","year":"2020","journal-title":"Clin. Kidney J."},{"issue":"4","key":"10.1016\/j.prp.2026.156631_bib38","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4274\/MMJ.galenos.2021.48447","article-title":"The Clinical Impact of Tumor Grade Heterogeneity in Non-muscle-invasive Urothelial Carcinoma of the Bladder","volume":"36","author":"Culpan","year":"2021","journal-title":"Medeni. Med. J."},{"issue":"11","key":"10.1016\/j.prp.2026.156631_bib39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/gm505","article-title":"Intra-tumor heterogeneity: lessons from microbial evolution and clinical implications","volume":"5","author":"de Bruin","year":"2013","journal-title":"Genome Med."},{"issue":"4","key":"10.1016\/j.prp.2026.156631_bib40","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1177\/10668969231189798","article-title":"Clear Cell Renal Cell Carcinoma With Syncytial-Type Multinucleated Giant Tumor Cells: A Clinicopathologic Study of 14 Cases","volume":"32","author":"Nova-Camacho","year":"2024","journal-title":"Int. J. Surg. Pathol."},{"issue":"4","key":"10.1016\/j.prp.2026.156631_bib41","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.humpath.2013.10.033","article-title":"Clear cell renal cell carcinoma with a syncytial-type multinucleated giant tumor cell component: implications for differential diagnosis","volume":"45","author":"Williamson","year":"2014","journal-title":"Hum. Pathol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826002840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826002840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T06:34:18Z","timestamp":1788762858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033826002840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":41,"alternative-id":["S0344033826002840"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156631","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An independent evaluation of an architectural-based scoring system for renal cell carcinoma risk-stratification","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156631","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"156631"}}